Medtech Products Inc., a subsidiary of Prestige Consumer Healthcare Inc., has issued a voluntary nationwide recall of five lots of Little Remedies® Honey Cough Syrup due to microbial contamination with Bacillus cereus and loss of shelf-stability. The recall affects 4 FL OZ (118 mL) bottles distributed across the United States from December 14, 2022, through June 4, 2025.
Health Risks and Symptoms
Bacillus cereus can cause two distinct types of foodborne illnesses. The first type is characterized by nausea, vomiting, and stomach cramps that can begin 1 to 6 hours after consuming contaminated products. The second type causes stomach cramps and diarrhea starting 8 to 16 hours after exposure, with diarrhea potentially ranging from small volume to profuse and watery.
According to the FDA announcement, while healthy individuals may experience only short-term illness, exposure to high levels of foodborne B. cereus can cause death. No serious adverse events have been reported to date in connection with this recall.
Recalled Product Details
The recall encompasses all lots of Little Remedies® Honey Cough Syrup in 4 FL OZ amber bottles that remain within their expiration dates. The affected products are packaged in outer cartons with lot codes appearing on both the bottle label and the bottom of the carton.
The specific recalled lots include:
- LOT 0039, EXP 11/2025
- LOT 0545, EXP 01/2026
- LOT 0640, EXP 02/2026
- LOT 0450, EXP 05/2026
- LOT 1198, EXP 12/2026
The products carry UPC 7-56184-10737-9 and were distributed through retail stores and online platforms nationwide. The cough syrup is intended for use by children one year and older.
Consumer Actions and Company Response
Consumers who possess recalled products should discontinue use immediately and contact their physician or healthcare provider if they have experienced any problems potentially related to the product. Medtech Products is offering full reimbursement for consumers who purchased products from the recalled lots.
The company can be contacted for refund requests or questions via email at medicalaffairs@prestigebrands.com, through their website at https://www.prestigebrands.com/contact, or by phone at (800) 754-8853 during business hours Monday through Friday, 8:30 AM to 5:30 PM Eastern Time.
The recall is being conducted with the knowledge of the U.S. Food and Drug Administration. Adverse reactions or quality problems can be reported to the FDA's MedWatch Adverse Event Reporting program online at www.fda.gov/medwatch/report.htm or by calling 1-800-332-1088.
